Back to search

Article

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson´s disease

2024-09-08

Abstract excerpt

<title>Abstract</title> <p>Background Neuroinflammation is a key feature of Parkinson´s disease (PD), a neurodegenerative disease for which there is no cure. The cannabinoid receptor type 2 (CB2R) is expressed by cells of the innate and adaptive immune systems. Inhibition of monoacylglycerol lipase increases the levels of the endocannabinoid 2-arachidonoylglycerol (2-AG), which is neuroprotective in an experimen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f397c01-e505-55a8-b48b-860b40ac710c
DOI
10.21203/rs.3.rs-4752464/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson´s diseaseDOI 10.21203/rs.3.rs-4752464/v1
Select a neighboring publication to make it the new centre.